|
Overview | Short
Courses | Day 1 (Joint Session) |
Day 2 | Day 3 | Download Brochure
Successes
in antibody therapeutics are revolutionizing the biotech and
pharmaceutical industry, thus driving the next-generation of antibody
research and development. Recent advances in antibody
selection and engineering techniques have led to the development of
antibodies specific for highly conserved targets, the creation of novel
antibody-based structures, significant improvements in affinity for target
antigens, enhanced ability to engage immune effector functions, and the
creation of fusion proteins with direct cytotoxic properties.
Cambridge Healthtech Institute’s Inaugural Creating the
Next-Generation of Antibodies: Capturing the Competitive Edge focuses
on novel technologies as well as the business strategies currently in use
to aid the advancement of next generation antibodies through the drug
development pipeline.
Pre-Conference Short Courses:
January 11, 2009
Protecting IP for Protein Therapeutics and Diagnostics
Program Management for Scientists
Joint Session:
ANTIBODIES IN TRANSLATION
A day-long focus on how to use the tools and strategies available to better design the successful antibody therapeutics of the future.
FEATURED SPEAKERS
Novel Targets for Autoimmunity and Infl ammatory Diseases Identified Using Viral Virulence Factors
Paul J. Carter, Ph.D., Chief Scientifi c Offi cer, Senior Vice President, Research & Development, VLST, Inc.
Transepithelial Delivery of Peptide and Protein Therapeutics
Rick Costantino, Ph.D., Chief Scientific Officer, Nastech
The Human Antibodyome – Implications for the Design of Therapeutic Antibodies and Vaccines
Dimiter Dimitrov, Ph.D., Senior Investigator, Protein Interaction Group, National Cancer Institute, National Institutes of Health (NIH)
A Human Protein Atlas
Mathias Uhlén, Ph.D., Professor, School of Biotechnology, Royal Institute of Technology
Pharmacokinetic and Pharmacodynamic Relationships
in Developing Novel mAb Therapeutics
Miro Venturi, Ph.D., Head, PK/PD Assay Development, Preclinical Sciences & Safety, Novartis Biologics
Overview | Short
Courses | Day 1 (Joint Session) |
Day 2 | Day 3 | Download Brochure
For more information, please contact:
Mary Ann Brown, Sr. Conference Director
Phone: 781-972-5497
E-mail: mabrown@healthtech.com
For exhibit and sponsorship information, please contact:
Suzanne Carroll, Manager-Business
Development
Phone: 781-972-5452
E-mail: scarroll@healthtech.com
|
